Making Coverage Count 

Does your CFTR assay provide the right coverage for everyone?

The AmplideX® PCR/CE CFTR Kit* was designed to provide the broadest CFTR coverage† of the U.S. population of any commercially available, targeted assay. 

Extending the simplicity and scalability of AmplideX technology to CFTR mutation testing, this kit provides coverage of approximately 92.2% of the U.S. population and delivers results in under five hours.

Additional links:

• View our Virtual Event on demand: Advances in Broad Coverage CFTR testing hosted by Labroots
• Practical and Reliable CFTR Variant Detection for Diverse Populations (AMP 2021)
• White paper
• Scientific Posters
• Video from AMP 2020
• Diagnostics World News Article

*For Research Use Only. Not for use in Diagnostic procedures. †Beauchamp, et al. Genet Med. 2019 Nov;21(11):2569-2576. Broad Institute Genome Aggregation Database (gnomAD).